According to GlobalData’s medical device pipeline database, 57 Computed Tomography (CT) Systems devices are in various stages of development globally. GlobalData’s report Computed Tomography (CT) Systems provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.
Smarter leaders trust GlobalData
Of these devices, 32 are in active development, while the remaining 25 are in an inactive stage of development. There are 16 products in the early stages of development, and the remaining 16 are in the late stages of development.
Computed Tomography (CT) is a powerful, non-destructive evaluation technique used for producing 2D and 3D cross-sectional image of an object from a flat X-ray image. Computed Tomography (CT) is used on patients with a high risk of colon cancer, or full-motion heart scans for patients with high risk of heart disease. It can also be used for image complex fractures, detect infarction, tumors, calcifications, hemorrhage and bone trauma and also acute and chronic changes in the lung parenchyma etc. The device includes a slice detector and an X-ray source. 256-320 slice CT Systems, 128-slice CT Systems, 64-slice CT Systems, 20-40 slice CT Systems and 16-slice and below CT Systems are tracked under this category. Tracked here under is the equipment only and not accessories and/or additional costs associated with CT installation. One unit refers to One CT system.
Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.
Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Computed Tomography (CT) Systems pipeline devices are all expected to be approved within the next ten years.
Currently, private organizations, public entities and institutions are working on the development of Computed Tomography (CT) Systems devices. Overall, most of these Computed Tomography (CT) Systems pipeline devices are being developed by private entities.
Key players involved in the active development of Computed Tomography (CT) Systems include Siemens Healthineers, FMI Medical Systems, GE HealthCare Technologies, Koninklijke Philips, TetraImaging, Stanford University, Stanford University, University of Washington, Xoran Technologies and ZumaTek.
For a complete picture of the developmental pipeline for Computed Tomography (CT) Systems devices, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. The Pipeline Products database is a is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
